Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8739512 | Journal of Autoimmunity | 2018 | 6 Pages |
Abstract
TBK1 inhibition reduced expression of ISGs in PBMCs from IFNpos patients with systemic autoimmune diseases indicating TBK1 as a potential treatment target.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Iris L.A. Bodewes, Erika Huijser, Cornelia G. van Helden-Meeuwsen, Liselotte Tas, Ruth Huizinga, Virgil A.S.H. Dalm, P. Martin van Hagen, Noortje Groot, Sylvia Kamphuis, Paul L.A. van Daele, Marjan A. Versnel,